BENDAMUSTINE MEDAC 2.5 mg/ml, powder for concentrate for infusion 5 bottles, CIP 3400955022213
Active ingredients: Bendamustine hydrochloride monohydrate, Bendamustine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Powder for concentrate for infusion5 bottles, CIP 3400955022213intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENDAMUSTINE MEDAC 2,5 mg/mL, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre brun de 25 mg de poudre
- Marketing authorisation holder
- MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64457346CIP75502221CIP133400955022213Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BENDAMUSTINE (CHLORHYDRATE DE) MONOHYDRATÉpoudre | — | SA |
| CHLORHYDRATE DE BENDAMUSTINEpoudre | 25 mg · un flacon de 25 mL | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.